Mercury Laboratories [MERCURYLAB] vs Sun Pharma Advanced [SPARC] Detailed Stock Comparison

Mercury Laboratories Ltd.

BSE
Loading...

Sun Pharma Advanced Research Company Ltd.

NSE
Loading...

TLDR: Quick Comparison Summary

Based on 20 vital metrics comparison: Mercury Laboratories Ltd. wins in 14 metrics, Sun Pharma Advanced Research Company Ltd. wins in 4 metrics, with 0 ties. Mercury Laboratories Ltd. appears stronger overall.

View Metrics Details

Vital Metrics Comparison

Metric Mercury Laboratories Ltd. Sun Pharma Advanced Research Company Ltd. Better
P/E Ratio (TTM) 18.15 -13.65 Mercury Laboratories Ltd.
Price-to-Book Ratio 1.54 -13.55 Mercury Laboratories Ltd.
Debt-to-Equity Ratio 10.77 -1.21 Mercury Laboratories Ltd.
PEG Ratio -1.11 -11.15 Mercury Laboratories Ltd.
EV/EBITDA 10.44 -22.27 Mercury Laboratories Ltd.
Profit Margin (TTM) 6.20% -53.22% Mercury Laboratories Ltd.
Operating Margin (TTM) 8.99% -700.71% Mercury Laboratories Ltd.
EBITDA Margin (TTM) 8.99% N/A N/A
Return on Equity 5.87% 157.88% Sun Pharma Advanced Research Company Ltd.
Return on Assets (TTM) 4.23% -102.08% Mercury Laboratories Ltd.
Free Cash Flow (TTM) $-50.39M $-3.71B Mercury Laboratories Ltd.
Dividend Yield 0.82% N/A N/A
1-Year Return -11.83% 34.88% Sun Pharma Advanced Research Company Ltd.
Price-to-Sales Ratio (TTM) 1.12 87.98 Mercury Laboratories Ltd.
Enterprise Value $887.85M $50.87B Sun Pharma Advanced Research Company Ltd.
EV/Revenue Ratio 1.17 95.73 Mercury Laboratories Ltd.
Gross Profit Margin (TTM) 61.64% -59.53% Mercury Laboratories Ltd.
Revenue per Share (TTM) $635 $2 Mercury Laboratories Ltd.
Earnings per Share (Diluted) $39.30 $-8.25 Mercury Laboratories Ltd.
Beta (Stock Volatility) 0.44 0.19 Sun Pharma Advanced Research Company Ltd.

Mercury Laboratories Ltd. vs Sun Pharma Advanced Research Company Ltd. Stock Performance Analysis

Loading Price Chart...

MERCURYLAB
SPARC

Performance Comparison

Short-term Returns

Stock1D1W1M3M6MYTD
Mercury Laboratories Ltd.-2.06%-2.39%-0.16%-5.13%-9.16%-9.32%
Sun Pharma Advanced Research Company Ltd.2.36%12.49%39.95%100.62%67.89%69.61%

Long-term Returns

Stock1Y3Y5Y10Y15Y20Y
Mercury Laboratories Ltd.-11.83%-5.41%16.63%72.97%2,064.80%2,064.80%
Sun Pharma Advanced Research Company Ltd.34.88%14.54%-3.55%-20.47%148.26%-23.02%

Performance & Financial Health Analysis: Mercury Laboratories Ltd. vs Sun Pharma Advanced Research Company Ltd.

MetricMERCURYLABSPARC
Market Information
Market Cap i₹855.84M₹46.75B
Market Cap CategorySmall capSmall cap
10 Day Avg. Volume i192,401,062
90 Day Avg. Volume i592,083,443
Last Close₹759.00₹229.03
52 Week Range₹620.55 - ₹976.00₹108.00 - ₹248.75
% from 52W High-22.23%-7.93%
All-Time High₹1,303.00 (Jan 08, 2024)₹875.00 (Apr 24, 2006)
% from All-Time High-41.75%-73.83%
Growth Metrics
Quarterly Revenue Growth-0.06%-0.43%
Quarterly Earnings Growth-0.16%-0.43%
Financial Health
Profit Margin (TTM) i0.06%-0.53%
Operating Margin (TTM) i0.09%-7.01%
Return on Equity (TTM) i0.06%1.58%
Debt to Equity (MRQ) i10.77-1.21
Cash & Liquidity
Book Value per Share (MRQ)₹464.51₹-10.63
Cash per Share (MRQ)₹23.55₹0.03
Operating Cash Flow (TTM) i₹-12,625,000₹-3,484,287,000
Levered Free Cash Flow (TTM) i₹31.45M₹-3,425,094,000
Dividends
Last 12-Month Dividend Yield i0.82%N/A
Last 12-Month Dividend i₹7.00N/A

Valuation & Enterprise Metrics Analysis: Mercury Laboratories Ltd. vs Sun Pharma Advanced Research Company Ltd.

MetricMERCURYLAB (Apr 26, 2026)SPARC (Apr 22, 2026)
Price Ratios
P/E Ratio (TTM) i18.15-13.65
Forward P/E iN/A2.60
PEG Ratio i-1.11-11.15
Price to Sales (TTM) i1.1287.98
Price to Book (MRQ) i1.54-13.55
Market Capitalization
Market Capitalization i₹855.84M₹46.75B
Enterprise Value i₹887.85M₹50.87B
Enterprise Value Metrics
Enterprise to Revenue i1.1795.73
Enterprise to EBITDA i10.44-22.27
Risk & Other Metrics
Beta i0.440.19
Book Value per Share (MRQ) i₹464.51₹-10.63

Financial Statements Comparison: Mercury Laboratories Ltd. vs Sun Pharma Advanced Research Company Ltd.

Financial Metrics

Loading Financial Charts...

Revenue

Operating Margin

Profit Margin

Long Term Debt

Income Flow Analysis

Financial Statements Comparison

Income Statement

MetricMERCURYLAB (2025)SPARC (2025)
Revenue/Sales i751.01M717.66M
Cost of Goods Sold i289.16M1.10B
COGS % of Revenue i38.5%153.2%
Gross Profit i461.85M-381.94M
Gross Margin i61.5%-53.2%
Research & Development iN/AN/A
Operating Income (EBIT) i74.14M-3.34B
Operating Margin i9.9%-465.5%
EBITDA i109.74M-3.23B
EBITDA Margin i14.6%-450.0%
Pre-Tax Income i46.62M-3.43B
Pre-Tax Income % of Revenue i6.2%-477.6%
Income Tax i15.17M-2.72M
Income Tax % of Revenue i2.0%-0.4%
Net Income (Profit) i31.45M-3.43B
Profit Margin i4.2%-477.3%

Balance Sheet & Liquidity Metrics

MetricMERCURYLAB (2025)SPARC (2025)
Cash & Equivalents i3.32M19.64M
Total Current Assets i401.60M261.97M
Total Current Assets % of Revenue i53.5%36.5%
Total Current Liabilities i150.76M3.74B
Total Current Liabilities % of Revenue i20.1%521.5%
Long-Term Debt i37.83M1.07B
Long-Term Debt % of Revenue i5.0%149.0%
Total Shareholders Equity i535.69M-2.17B
Retained Earnings i86.56M-23.22B
Retained Earnings % of Revenue i11.5%-3,235.0%
Property, Plant & Equipment i85.40M178.02M

Cash Flow Statement Comparison

MetricMERCURYLAB (2025)SPARC (2025)
Operating Cash Flow i-12.63M-3.48B
Operating Cash Flow % of Revenue i-1.7%-485.5%
Capital Expenditures i-90.40M-97.45M
Free Cash Flow i-50.39M-3.71B
FCF Margin i-6.7%-516.4%
Debt Repayment iN/A-3.69B
Common Stock Repurchase iN/AN/A

Short Interest & Institutional Ownership Analysis

MetricMERCURYLABSPARC
Shares Short iN/AN/A
Short Ratio iN/AN/A
Short % of Float iN/AN/A
Shares Outstanding i1.20M324.52M
Float Shares i165,47091.32M
% Held by Insiders i86.33%72.96%
% Held by Institutions i0.00%2.56%
% Held by Public i13.67%24.48%

Dividend Analysis & Yield Comparison: Mercury Laboratories Ltd. vs Sun Pharma Advanced Research Company Ltd.

MetricMERCURYLABSPARC
Last 12-Month Dividend i₹7.00N/A
Last 12-Month Dividend Yield i0.82%N/A
3-Year Avg Annual Dividend i₹4.67N/A
3-Year Avg Dividend Yield i0.43%N/A
3-Year Total Dividends i₹14.00N/A
Ex-Dividend DateAug 06, 2025N/A